Search Orphan Drug Designations and Approvals
-
Generic Name: | nimotuzumab |
---|---|
Date Designated: | 09/08/2015 |
Orphan Designation: | Treatment of pancreatic cancer. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
InnoCIMab Pte Ltd 21 Bukit Batok Crescent WCEGA Tower #14-78 Singapore The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-